Search

everythinglearnresearchcommunity

for

Search:↓

EGCG shows strong electron transfer interactions when bonded to DPPG lipids.

COVID-19 doesn't make alopecia areata worse.

Overexpressing AVP1 and AtNHX1 in plants improves salt tolerance and root hair development.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

PRP treatment may help with alopecia areata, especially in newer cases.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

The modified Isabgol dressing effectively heals wounds by preventing infections and maintaining moisture.